Navvia & DVMS Institute partner to deliver next-gen cyber governance, resilience & training via Navvia’s NIST CSF assessment & process modeling platform. We are thrilled to partner with Navvia to ...
Durvalumab improves long-term outcome in TNBC: results from the phase II randomized GeparNUEVO study investigating neodjuvant durvalumab in addition to an anthracycline/taxane based neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results